Jump to content

Gene Editing Patent Application Trends 2025: Difference between revisions

From WikiPatents
← Older edit
Updating Gene Editing Patent Application Trends 2025
Updating Gene Editing Patent Application Trends 2025
 
Line 1: Line 1:
== Gene Editing Patent Application Filing Activity ==
== Gene Editing Patent Application Filing Activity ==
== Gene Editing patent applications in 2025 ==
== Gene Editing patent applications in 2025 ==
[[File:Gene_Editing_Monthly_Patent_Applications_2025_-_Up_to_March 2025.png|border|800px]]
[[File:Gene_Editing_Monthly_Patent_Applications_2025_-_Up_to_May 2025.png|border|800px]]


== Top Technology Areas in Gene Editing ==
== Top Technology Areas in Gene Editing ==
[[File:Top_Technology_Areas_in_Gene_Editing_2025_-_Up_to_March 2025.png|border|800px]]
[[File:Top_Technology_Areas_in_Gene_Editing_2025_-_Up_to_May 2025.png|border|800px]]


=== Top CPC Codes ===
=== Top CPC Codes ===
* [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available)
* [[:Category:CPC_C12N9/22|C12N9/22]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media)
** Count: 117 patents
** Count: 194 patents
** Example: [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]]
** Example: [[20250113820. CRYOGENICALLY ARRAYABLE STABLE TRANSFECTION (Synthego Corporation)]]
* [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available)
* [[:Category:CPC_C12N2310/20|C12N2310/20]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media)
** Count: 108 patents
** Count: 184 patents
** Example: [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]]
** Example: [[20250113820. CRYOGENICALLY ARRAYABLE STABLE TRANSFECTION (Synthego Corporation)]]
* [[:Category:CPC_C12N15/11|C12N15/11]] (No explanation available)
* [[:Category:CPC_C12N15/11|C12N15/11]] (DNA or RNA fragments; Modified forms thereof  (DNA or RNA not used in recombinant technology,)
** Count: 60 patents
** Count: 106 patents
** Example: [[20250034558. COMPOSITIONS AND METHODS FOR TARGETING, EDITING OR MODIFYING HUMAN GENES (Artisan Development Labs, Inc.)]]
** Example: [[20250115875. COMPOSITIONS AND METHODS FOR CELL ENGINEERING FOR MEAT PRODUCTION (Fork & Goode, Inc.)]]
* [[:Category:CPC_C12N15/86|C12N15/86]] (No explanation available)
* [[:Category:CPC_C12N15/86|C12N15/86]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media)
** Count: 55 patents
** Count: 96 patents
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
** Example: [[20250114480. GENE THERAPY FOR GENETIC HEARING LOSS (BridgeBio Gene Therapy Research, Inc.)]]
* [[:Category:CPC_C12N2750/14143|C12N2750/14143]] (No explanation available)
* [[:Category:CPC_C12N2750/14143|C12N2750/14143]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media)
** Count: 49 patents
** Count: 85 patents
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
** Example: [[20250114480. GENE THERAPY FOR GENETIC HEARING LOSS (BridgeBio Gene Therapy Research, Inc.)]]
* [[:Category:CPC_C12N15/907|C12N15/907]] (No explanation available)
* [[:Category:CPC_C12N15/907|C12N15/907]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media)
** Count: 44 patents
** Count: 73 patents
** Example: [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]]
** Example: [[20250114482. THERAPEUTIC APPLICATIONS OF CPF1-BASED GENOME EDITING (Duke University)]]
* [[:Category:CPC_C12N15/111|C12N15/111]] (No explanation available)
* [[:Category:CPC_C12N15/111|C12N15/111]] ({General methods applicable to biologically active non-coding nucleic acids})
** Count: 40 patents
** Count: 65 patents
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
** Example: [[20250113820. CRYOGENICALLY ARRAYABLE STABLE TRANSFECTION (Synthego Corporation)]]
* [[:Category:CPC_A61K48/005|A61K48/005]] (No explanation available)
* [[:Category:CPC_A61K48/0058|A61K48/0058]] (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy)
** Count: 22 patents
** Count: 39 patents
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
** Example: [[20250114482. THERAPEUTIC APPLICATIONS OF CPF1-BASED GENOME EDITING (Duke University)]]
* [[:Category:CPC_A61K48/0058|A61K48/0058]] (No explanation available)
* [[:Category:CPC_A61K48/005|A61K48/005]] (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy)
** Count: 22 patents
** Count: 36 patents
** Example: [[20250064978. GENE THERAPY METHODS FOR TREATMENT OF DIABETES (Jaguar Gene Therapy, LLC)]]
** Example: [[20250114480. GENE THERAPY FOR GENETIC HEARING LOSS (BridgeBio Gene Therapy Research, Inc.)]]
* [[:Category:CPC_C12N15/113|C12N15/113]] (No explanation available)
* [[:Category:CPC_C12N15/113|C12N15/113]] (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing  (when used in plants)
** Count: 21 patents
** Count: 35 patents
** Example: [[20250034562. COMPOSITIONS AND METHODS FOR IMPROVING THE EFFICACY OF CAS9-BASED KNOCK-IN STRATEGIES (ASTRAZENECA AB)]]
** Example: [[20250114482. THERAPEUTIC APPLICATIONS OF CPF1-BASED GENOME EDITING (Duke University)]]


== Top Companies in Gene Editing 2025 ==
== Top Companies in Gene Editing 2025 ==
Line 42: Line 42:


=== [[:Category:The Regents of the University of California|The Regents of the University of California]] ===
=== [[:Category:The Regents of the University of California|The Regents of the University of California]] ===
* Number of Gene Editing patents: 7
* Number of Gene Editing patents: 14
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 4 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 10 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 4 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 10 patents
** [[:Category:CPC_A61K48/005|A61K48/005]] (No explanation available): 2 patents
** [[:Category:CPC_C12N15/11|C12N15/11]] (DNA or RNA fragments; Modified forms thereof  (DNA or RNA not used in recombinant technology,): 6 patents
* Recent patents:
* Recent patents:
** [[20250092391. PROMOTERS FOR VIRAL-BASED GENE THERAPY (The Regents of the University of California)]] (20250320)
** [[20250145959. COMPOSITIONS AND METHODS FOR PRODUCING SMOOTH MUSCLE CELLS (The Regents of the University of California)]] (20250508)
** [[20250049960. Multicomponent systems for site-specific genome modifications (The Regents of the University of California)]] (20250213)
** [[20250145968. GENETIC ENGINEERING OF BACTERIOPHAGES USING CRISPR-CAS13A (The Regents of the University of California)]] (20250508)
** [[20250101385. GENE EDITING TO IMPROVE PANCREATIC BETA CELL YIELD IN DIRECTED DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS (The Regents of the University of California)]] (20250327)
** [[20250101385. GENE EDITING TO IMPROVE PANCREATIC BETA CELL YIELD IN DIRECTED DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS (The Regents of the University of California)]] (20250327)
=== [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]] ===
=== [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]] ===
* Number of Gene Editing patents: 5
* Number of Gene Editing patents: 13
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 5 patents
** [[:Category:CPC_G02B1/002|G02B1/002]] (Optical elements characterised by the material of which they are made; Optical coatings for optical elements): 6 patents
** [[:Category:CPC_C12N15/111|C12N15/111]] (No explanation available): 3 patents
** [[:Category:CPC_G02B2207/101|G02B2207/101]] (OPTICAL ELEMENTS, SYSTEMS OR APPARATUS): 5 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 3 patents
** [[:Category:CPC_G02B13/0055|G02B13/0055]] ({employing a special optical element}): 4 patents
* Recent patents:
* Recent patents:
** [[20250101400. NOVEL CRISPR ENZYMES AND SYSTEMS (The Broad Institute, Inc.)]] (20250327)
** [[20250123466. HYBRID LENS AND OPTICAL SYSTEM (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
** [[20250101468. DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY (The Broad Institute, Inc.)]] (20250327)
** [[20250123468. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
** [[20250101500. AMPLIFICATION ASSAYS USING CRISPR-CAS BASED DETECTION (The Broad Institute, Inc.)]] (20250327)
** [[20250123469. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
=== [[:Category:THE BROAD INSTITUTE, INC.|THE BROAD INSTITUTE, INC.]] ===
=== [[:Category:THE BROAD INSTITUTE, INC.|THE BROAD INSTITUTE, INC.]] ===
* Number of Gene Editing patents: 4
* Number of Gene Editing patents: 6
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 3 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 5 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 3 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 5 patents
** [[:Category:CPC_C12Q1/6823|C12Q1/6823]] (No explanation available): 1 patents
** [[:Category:CPC_C12N15/907|C12N15/907]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 3 patents
* Recent patents:
* Recent patents:
** [[20250043366. TILED ASSAYS USING CRISPR-CAS BASED DETECTION (THE BROAD INSTITUTE, INC.)]] (20250206)
** [[20250171756. NOVEL TYPE VI CRISPR ENZYMES AND SYSTEMS (THE BROAD INSTITUTE, INC.)]] (20250529)
** [[20250075268. CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS (THE BROAD INSTITUTE, INC.)]] (20250306)
** [[20250171811. TYPE I-B CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS (THE BROAD INSTITUTE, INC.)]] (20250529)
** [[20250099623. COMPOSITIONS AND METHODS FOR ENHANCING INTRA-MITOCHONDRIAL PROTEIN TRANSLATION AND OXIDATIVE PHOSPHORYLATION (THE BROAD INSTITUTE, INC.)]] (20250327)
** [[20250099623. COMPOSITIONS AND METHODS FOR ENHANCING INTRA-MITOCHONDRIAL PROTEIN TRANSLATION AND OXIDATIVE PHOSPHORYLATION (THE BROAD INSTITUTE, INC.)]] (20250327)
=== [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]] ===
=== [[:Category:PIONEER HI-BRED INTERNATIONAL, INC.|PIONEER HI-BRED INTERNATIONAL, INC.]] ===
* Number of Gene Editing patents: 4
* Number of Gene Editing patents: 6
* Top CPC codes:
** [[:Category:CPC_C12N9/22|C12N9/22]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 5 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 5 patents
** [[:Category:CPC_C12N15/8213|C12N15/8213]] ({Targeted insertion of genes into the plant genome by homologous recombination}): 3 patents
* Recent patents:
** [[20250122513. GENERATION OF SITE SPECIFIC INTEGRATION SITES FOR COMPLEX TRAIT LOCI IN CORN AND SOYBEAN, AND METHODS OF USE (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250417)
** [[20250122536. NOVEL CAS9 ORTHOLOGS (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250417)
** [[20250011804. INTERACTORS AND TARGETS FOR IMPROVING PLANT AGRONOMIC CHARACTERISTICS (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250109)
=== [[:Category:The Trustees of Columbia University in the City of New York|The Trustees of Columbia University in the City of New York]] ===
* Number of Gene Editing patents: 5
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_G01S7/4816|G01S7/4816]] (No explanation available): 1 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 3 patents
** [[:Category:CPC_G02B13/0055|G02B13/0055]] (No explanation available): 1 patents
** [[:Category:CPC_C12N15/11|C12N15/11]] (DNA or RNA fragments; Modified forms thereof  (DNA or RNA not used in recombinant technology,): 3 patents
** [[:Category:CPC_G02B13/008|G02B13/008]] (No explanation available): 1 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 3 patents
* Recent patents:
* Recent patents:
** [[20250060582. DESIGN METHOD FOR METALENS, METALENS, SHAPING AND BEAM-COMBINATION DEVICE AND DISPLAY DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250171810. COMPOSITIONS, SYSTEMS, AND METHODS FOR PRIME EDITING (The Trustees of Columbia University in the City of New York)]] (20250529)
** [[20250063841. METHOD FOR DESIGNING METALENS USED FOR IMAGE SENSOR (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250163410. CRISPR-TRANSPOSON SYSTEMS FOR DNA MODIFICATION (The Trustees of Columbia University in the City of New York)]] (20250522)
** [[20250085533. OPTICAL SYSTEM AND OPTICAL CAMERA WORKING AT FAR-INFRARED WAVEBAND (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250313)
** [[20250098652. Genetic Modifications for Xenotransplantation (The Trustees of Columbia University in the City of New York)]] (20250327)
=== [[:Category:EmendoBio Inc.|EmendoBio Inc.]] ===
=== [[:Category:Tune Therapeutics, Inc.|Tune Therapeutics, Inc.]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 5
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 3 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 5 patents
** [[:Category:CPC_C12N15/11|C12N15/11]] (No explanation available): 3 patents
** [[:Category:CPC_C12N15/11|C12N15/11]] (DNA or RNA fragments; Modified forms thereof  (DNA or RNA not used in recombinant technology,): 5 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 3 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 5 patents
* Recent patents:
* Recent patents:
** [[20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.)]] (20250130)
** [[20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250501)
** [[20250051741. OMNI-103 CRISPR NUCLEASE (EmendoBio Inc.)]] (20250213)
** [[20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250529)
** [[20250011740. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES (EmendoBio Inc.)]] (20250109)
** [[20250154503. COMPOSITIONS, SYSTEMS, AND METHODS FOR PROGRAMMING T CELL PHENOTYPES THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250515)
=== [[:Category:The Trustees of Columbia University in the City of New York|The Trustees of Columbia University in the City of New York]] ===
=== [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 5
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C12Q1/6869|C12Q1/6869]] (No explanation available): 1 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 5 patents
** [[:Category:CPC_C07H19/10|C07H19/10]] (No explanation available): 1 patents
** [[:Category:CPC_C12N15/111|C12N15/111]] ({General methods applicable to biologically active non-coding nucleic acids}): 3 patents
** [[:Category:CPC_C07H21/00|C07H21/00]] (No explanation available): 1 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 3 patents
* Recent patents:
* Recent patents:
** [[20250066848. DNA SEQUENCING BY SYNTHESIS USING MODIFIED NUCLEOTIDES AND NANOPORE DETECTION (The Trustees of Columbia University in the City of New York)]] (20250227)
** [[20250101400. NOVEL CRISPR ENZYMES AND SYSTEMS (The Broad Institute, Inc.)]] (20250327)
** [[20250075234. COMPOSITIONS AND METHODS FOR BASE EDITING KINASE GENES (The Trustees of Columbia University in the City of New York)]] (20250306)
** [[20250101468. DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY (The Broad Institute, Inc.)]] (20250327)
** [[20250098652. Genetic Modifications for Xenotransplantation (The Trustees of Columbia University in the City of New York)]] (20250327)
** [[20250101500. AMPLIFICATION ASSAYS USING CRISPR-CAS BASED DETECTION (The Broad Institute, Inc.)]] (20250327)
=== [[:Category:Christiana Care Gene Editing Institute, Inc.|Christiana Care Gene Editing Institute, Inc.]] ===
=== [[:Category:CRISPR THERAPEUTICS AG|CRISPR THERAPEUTICS AG]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 5
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_A61P35/00|A61P35/00]] (No explanation available): 3 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 5 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 3 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 4 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 3 patents
** [[:Category:CPC_A61K9/5123|A61K9/5123]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 3 patents
* Recent patents:
* Recent patents:
** [[20250001010. NRAS GENE KNOCKOUT FOR TREATMENT OF CANCER (Christiana Care Gene Editing Institute, Inc.)]] (20250102)
** [[20250145998. COMPOSITIONS AND METHODS FOR GENE EDITING BY TARGETING TRANSFERRIN (CRISPR THERAPEUTICS AG)]] (20250508)
** [[20250018060. ADENOVIRUS DELIVERY SYSTEM FOR CANCER TREATMENT (Christiana Care Gene Editing Institute, Inc.)]] (20250116)
** [[20250011771. METHODS AND COMPOSITIONS FOR TREATING LIPOPROTEIN-RELATED DISEASES (CRISPR THERAPEUTICS AG)]] (20250109)
** [[20250099556. METHODS OF AND COMPOSITIONS FOR REDUCING GENE EXPRESSION AND/OR ACTIVITY (Christiana Care Gene Editing Institute, Inc.)]] (20250327)
** [[20250101439. MATERIALS AND METHODS FOR CONTROLLING GENE EDITING (CRISPR THERAPEUTICS AG)]] (20250327)
=== [[:Category:The Trustees of the University of Pennsylvania|The Trustees of the University of Pennsylvania]] ===
=== [[:Category:The Trustees of the University of Pennsylvania|The Trustees of the University of Pennsylvania]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 4
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C12N15/86|C12N15/86]] (No explanation available): 2 patents
** [[:Category:CPC_C12N15/86|C12N15/86]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 3 patents
** [[:Category:CPC_C12N2750/14143|C12N2750/14143]] (No explanation available): 2 patents
** [[:Category:CPC_C12N2750/14143|C12N2750/14143]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 3 patents
** [[:Category:CPC_C12N2830/48|C12N2830/48]] (No explanation available): 2 patents
** [[:Category:CPC_A61K48/0075|A61K48/0075]] (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy): 2 patents
* Recent patents:
* Recent patents:
** [[20250041445. GENE THERAPY FOR TREATMENT OF MUCOPOLYSACCHARIDOSIS IIIA (The Trustees of the University of Pennsylvania)]] (20250206)
** [[20250161493. COMPOSITIONS AND METHODS FOR IN VIVO NUCLEASE-MEDIATED TREATMENT OF ORNITHINE TRANSCARBAMYLASE (OTC) DEFICIENCY (The Trustees of the University of Pennsylvania)]] (20250522)
** [[20250027900. pH Sensing Technique Based On Graphene Electrodes (The Trustees of the University of Pennsylvania)]] (20250123)
** [[20250027900. pH Sensing Technique Based On Graphene Electrodes (The Trustees of the University of Pennsylvania)]] (20250123)
** [[20250049949. GENE THERAPY FOR LAMIN A-ASSOCIATED DEFICIENCIES (The Trustees of the University of Pennsylvania)]] (20250213)
** [[20250049949. GENE THERAPY FOR LAMIN A-ASSOCIATED DEFICIENCIES (The Trustees of the University of Pennsylvania)]] (20250213)
=== [[:Category:CRISPR Therapeutics AG|CRISPR Therapeutics AG]] ===
=== [[:Category:Illumina, Inc.|Illumina, Inc.]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 4
* Top CPC codes:
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 3 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 3 patents
** [[:Category:CPC_A61P3/00|A61P3/00]] (No explanation available): 2 patents
* Recent patents:
** [[20250043261. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250206)
** [[20250027087. MODULATING EXPRESSION OF ALAS1 (5'-AMINOLEVULINATE SYNTHASE 1) GENE (CRISPR Therapeutics AG)]] (20250123)
** [[20250011743. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250109)
=== [[:Category:PIONEER HI-BRED INTERNATIONAL, INC.|PIONEER HI-BRED INTERNATIONAL, INC.]] ===
* Number of Gene Editing patents: 3
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 2 patents
** [[:Category:CPC_G06T7/0014|G06T7/0014]] ({using an image reference approach}): 2 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 2 patents
** [[:Category:CPC_G06T7/0012|G06T7/0012]] ({Biomedical image inspection}): 2 patents
** [[:Category:CPC_C12N15/8213|C12N15/8213]] (No explanation available): 2 patents
** [[:Category:CPC_G06T7/246|G06T7/246]] (using feature-based methods, e.g. the tracking of corners or segments): 2 patents
* Recent patents:
* Recent patents:
** [[20250075197. ENGINEERED DEAMINASES (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250306)
** [[20250166733. DETERMINING STRUCTURAL VARIANTS (Illumina, Inc.)]] (20250522)
** [[20250027097. HIGH EFFICIENCY LARGE SCALE CHROMOSOMAL GENOME MANIPULATION (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250123)
** [[20250148603. CREATING A TEMPLATE OF NUCLEIC ACID SITE LOCATIONS ON A FLOW CELL (Illumina, Inc.)]] (20250508)
** [[20250011804. INTERACTORS AND TARGETS FOR IMPROVING PLANT AGRONOMIC CHARACTERISTICS (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250109)
** [[20250148604. ANALYZING IMAGE DATA FROM NUCLEIC ACID SEQUENCING (Illumina, Inc.)]] (20250508)


== New Companies in Gene Editing (Last Month) ==
== New Companies in Gene Editing (Last Month) ==
Line 150: Line 150:
[[File:Emerging_Technology_Areas_in_Gene_Editing.png|border|800px]]
[[File:Emerging_Technology_Areas_in_Gene_Editing.png|border|800px]]


* [[:Category:CPC_C12Q2600/112|C12Q2600/112]] (No explanation available)
* [[:Category:CPC_C12Y302/0101|C12Y302/0101]] (ENZYMES)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250101528. USES OF CELL-FREE DNA FRAGMENTATION PATTERNS ASSOCIATED WITH EPIGENETIC MODIFICATIONS (Centre for Novostics)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_C12Y302/0101|C12Y302/0101]] (No explanation available)
* [[:Category:CPC_C12Y301/03024|C12Y301/03024]] (ENZYMES)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_C12Y301/03024|C12Y301/03024]] (No explanation available)
* [[:Category:CPC_C12Y301/0301|C12Y301/0301]] (ENZYMES)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_C12Y301/0301|C12Y301/0301]] (No explanation available)
* [[:Category:CPC_C12Y301/03009|C12Y301/03009]] (ENZYMES)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_C12Y301/03009|C12Y301/03009]] (No explanation available)
* [[:Category:CPC_C12Y207/07027|C12Y207/07027]] (ENZYMES)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_C12Y207/07027|C12Y207/07027]] (No explanation available)
* [[:Category:CPC_C12Y207/07009|C12Y207/07009]] (ENZYMES)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_C12Y207/07009|C12Y207/07009]] (No explanation available)
* [[:Category:CPC_C12Y207/01002|C12Y207/01002]] (ENZYMES)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_C12Y207/01002|C12Y207/01002]] (No explanation available)
* [[:Category:CPC_C12Y207/01001|C12Y207/01001]] (ENZYMES)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_C12Y207/01001|C12Y207/01001]] (No explanation available)
* [[:Category:CPC_C12Y204/01014|C12Y204/01014]] (ENZYMES)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_C12Y204/01014|C12Y204/01014]] (No explanation available)
* [[:Category:CPC_C12P19/12|C12P19/12]] (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
Line 184: Line 184:
[[File:Top_Companies_in_Emerging_Gene_Editing_Technologies.png|border|800px]]
[[File:Top_Companies_in_Emerging_Gene_Editing_Technologies.png|border|800px]]


* [[:Category:SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY|SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY]]: 9 patents
* [[:Category:SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY|SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY]]: 10 patents
* [[:Category:Centre for Novostics|Centre for Novostics]]: 1 patents


== Top Inventors in Gene Editing ==
== Top Inventors in Gene Editing ==
Line 191: Line 190:


=== [[:Category:Chenglong HAO|Chenglong HAO]] ===
=== [[:Category:Chenglong HAO|Chenglong HAO]] ===
* Number of Gene Editing patents: 4
* Number of Gene Editing patents: 13
* Top companies:
* Top companies:
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 4 patents
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 13 patents
* Recent patents:
* Recent patents:
** [[20250060582. DESIGN METHOD FOR METALENS, METALENS, SHAPING AND BEAM-COMBINATION DEVICE AND DISPLAY DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250123466. HYBRID LENS AND OPTICAL SYSTEM (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
** [[20250063841. METHOD FOR DESIGNING METALENS USED FOR IMAGE SENSOR (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250123468. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
** [[20250085533. OPTICAL SYSTEM AND OPTICAL CAMERA WORKING AT FAR-INFRARED WAVEBAND (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250313)
** [[20250123469. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
=== [[:Category:Fengze TAN|Fengze TAN]] ===
=== [[:Category:Fengze TAN|Fengze TAN]] ===
* Number of Gene Editing patents: 4
* Number of Gene Editing patents: 13
* Top companies:
* Top companies:
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 4 patents
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 13 patents
* Recent patents:
* Recent patents:
** [[20250060582. DESIGN METHOD FOR METALENS, METALENS, SHAPING AND BEAM-COMBINATION DEVICE AND DISPLAY DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250123466. HYBRID LENS AND OPTICAL SYSTEM (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
** [[20250063841. METHOD FOR DESIGNING METALENS USED FOR IMAGE SENSOR (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250123468. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
** [[20250085533. OPTICAL SYSTEM AND OPTICAL CAMERA WORKING AT FAR-INFRARED WAVEBAND (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250313)
** [[20250123469. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
=== [[:Category:Jian ZHU|Jian ZHU]] ===
=== [[:Category:Jian ZHU|Jian ZHU]] ===
* Number of Gene Editing patents: 4
* Number of Gene Editing patents: 13
* Top companies:
* Top companies:
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 4 patents
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 13 patents
* Recent patents:
* Recent patents:
** [[20250060582. DESIGN METHOD FOR METALENS, METALENS, SHAPING AND BEAM-COMBINATION DEVICE AND DISPLAY DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250123466. HYBRID LENS AND OPTICAL SYSTEM (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
** [[20250063841. METHOD FOR DESIGNING METALENS USED FOR IMAGE SENSOR (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250123468. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
** [[20250085533. OPTICAL SYSTEM AND OPTICAL CAMERA WORKING AT FAR-INFRARED WAVEBAND (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250313)
** [[20250123469. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
=== [[:Category:Feng Zhang|Feng Zhang of Cambridge MA (US)]] ===
=== [[:Category:Feng Zhang|Feng Zhang of Cambridge MA (US)]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 5
* Top companies:
* Top companies:
** [[:Category:THE BROAD INSTITUTE, INC.|THE BROAD INSTITUTE, INC.]]: 2 patents
** [[:Category:THE BROAD INSTITUTE, INC.|THE BROAD INSTITUTE, INC.]]: 4 patents
** [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]]: 1 patents
** [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250034622. SMALL NOVEL CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF (THE BROAD INSTITUTE, INC.)]] (20250130)
** [[20250171756. NOVEL TYPE VI CRISPR ENZYMES AND SYSTEMS (THE BROAD INSTITUTE, INC.)]] (20250529)
** [[20250075268. CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS (THE BROAD INSTITUTE, INC.)]] (20250306)
** [[20250171811. TYPE I-B CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS (THE BROAD INSTITUTE, INC.)]] (20250529)
** [[20250101400. NOVEL CRISPR ENZYMES AND SYSTEMS (The Broad Institute, Inc.)]] (20250327)
** [[20250101400. NOVEL CRISPR ENZYMES AND SYSTEMS (The Broad Institute, Inc.)]] (20250327)
=== [[:Category:JOSHUA K. YOUNG|JOSHUA K. YOUNG of JOHNSTON IA (US)]] ===
* Number of Gene Editing patents: 4
* Top companies:
** [[:Category:PIONEER HI-BRED INTERNATIONAL, INC.|PIONEER HI-BRED INTERNATIONAL, INC.]]: 4 patents
* Recent patents:
** [[20250163393. METHODS AND COMPOSITIONS FOR ADVANCED BREEDING THROUGH TARGETED CHROMOSOME ENGINEERING (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250522)
** [[20250027097. HIGH EFFICIENCY LARGE SCALE CHROMOSOMAL GENOME MANIPULATION (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250123)
** [[20250122536. NOVEL CAS9 ORTHOLOGS (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250417)
=== [[:Category:Chris RAMSBORG|Chris RAMSBORG of Seattle WA (US)]] ===
* Number of Gene Editing patents: 4
* Top companies:
** [[:Category:Juno Therapeutics, Inc.|Juno Therapeutics, Inc.]]: 4 patents
* Recent patents:
** [[20250161450. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250522)
** [[20250152712. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250515)
** [[20250121062. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250417)
=== [[:Category:Mark L. BONYHADI|Mark L. BONYHADI of Sammamish WA (US)]] ===
* Number of Gene Editing patents: 4
* Top companies:
** [[:Category:Juno Therapeutics, Inc.|Juno Therapeutics, Inc.]]: 4 patents
* Recent patents:
** [[20250161450. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250522)
** [[20250152712. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250515)
** [[20250121062. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250417)
=== [[:Category:Calvin CHAN|Calvin CHAN of Seattle WA (US)]] ===
* Number of Gene Editing patents: 4
* Top companies:
** [[:Category:Juno Therapeutics, Inc.|Juno Therapeutics, Inc.]]: 4 patents
* Recent patents:
** [[20250161450. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250522)
** [[20250152712. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250515)
** [[20250121062. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250417)
=== [[:Category:Pascal BEAUCHESNE|Pascal BEAUCHESNE of Seattle WA (US)]] ===
* Number of Gene Editing patents: 4
* Top companies:
** [[:Category:Juno Therapeutics, Inc.|Juno Therapeutics, Inc.]]: 4 patents
* Recent patents:
** [[20250161450. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250522)
** [[20250152712. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250515)
** [[20250121062. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250417)
=== [[:Category:Alexandra Briner Crawley|Alexandra Briner Crawley of Cary NC (US)]] ===
=== [[:Category:Alexandra Briner Crawley|Alexandra Briner Crawley of Cary NC (US)]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 3
Line 241: Line 280:
** [[20250043315. RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250206)
** [[20250043315. RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250206)
** [[20250092398. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (Life Edit Therapeutics, Inc.)]] (20250320)
** [[20250092398. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (Life Edit Therapeutics, Inc.)]] (20250320)
=== [[:Category:Brian COSGROVE|Brian COSGROVE of Durham NC (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
** [[:Category:Tune Therapeutics, Inc.|Tune Therapeutics, Inc.]]: 3 patents
* Recent patents:
** [[20250129369. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250424)
** [[20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250501)
** [[20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250529)
=== [[:Category:Kendra CONGDON|Kendra CONGDON of Durham NC (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
** [[:Category:Tune Therapeutics, Inc.|Tune Therapeutics, Inc.]]: 3 patents
* Recent patents:
** [[20250129369. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250424)
** [[20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250501)
** [[20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250529)
=== [[:Category:Jason DEAN|Jason DEAN of Seattle WA (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
** [[:Category:Tune Therapeutics, Inc.|Tune Therapeutics, Inc.]]: 3 patents
* Recent patents:
** [[20250129369. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250424)
** [[20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250501)
** [[20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250529)
=== [[:Category:Veronica GOUGH|Veronica GOUGH of Durham NC (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
** [[:Category:Tune Therapeutics, Inc.|Tune Therapeutics, Inc.]]: 3 patents
* Recent patents:
** [[20250129369. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250424)
** [[20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250501)
** [[20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250529)
=== [[:Category:Joshua B. BLACK|Joshua B. BLACK of Durham NC (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
** [[:Category:Tune Therapeutics, Inc.|Tune Therapeutics, Inc.]]: 3 patents
* Recent patents:
** [[20250129369. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250424)
** [[20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250501)
** [[20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250529)
=== [[:Category:Britta JONES|Britta JONES of Durham NC (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
** [[:Category:Tune Therapeutics, Inc.|Tune Therapeutics, Inc.]]: 3 patents
* Recent patents:
** [[20250129369. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250424)
** [[20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250501)
** [[20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250529)
=== [[:Category:Heshan LIN|Heshan LIN]] ===
* Number of Gene Editing patents: 3
* Top companies:
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 3 patents
* Recent patents:
** [[20250130399. OPTICAL SYSTEM AND OPTICAL CAMERA (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250424)
** [[20250138162. OPTICAL SYSTEM FOR ToF AND DEPTH CAMERA OF ToF (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250501)
** [[20250085533. OPTICAL SYSTEM AND OPTICAL CAMERA WORKING AT FAR-INFRARED WAVEBAND (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250313)
=== [[:Category:ZHENGLIN HOU|ZHENGLIN HOU of ANKENY IA (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
** [[:Category:PIONEER HI-BRED INTERNATIONAL, INC.|PIONEER HI-BRED INTERNATIONAL, INC.]]: 3 patents
* Recent patents:
** [[20250075197. ENGINEERED DEAMINASES (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250306)
** [[20250122536. NOVEL CAS9 ORTHOLOGS (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250417)
** [[20250011804. INTERACTORS AND TARGETS FOR IMPROVING PLANT AGRONOMIC CHARACTERISTICS (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250109)
=== [[:Category:Jonathan Gootenberg|Jonathan Gootenberg of Cambridge MA (US)]] ===
=== [[:Category:Jonathan Gootenberg|Jonathan Gootenberg of Cambridge MA (US)]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 3
Line 251: Line 354:
** [[20250092390. SYSTEMS, METHODS, AND COMPOSITIONS FOR SITE-SPECIFIC GENETIC ENGINEERING USING PROGRAMMABLE ADDITION VIA SITE-SPECIFIC TARGETING ELEMENTS (PASTE) (Massachusetts Institute of Technology)]] (20250320)
** [[20250092390. SYSTEMS, METHODS, AND COMPOSITIONS FOR SITE-SPECIFIC GENETIC ENGINEERING USING PROGRAMMABLE ADDITION VIA SITE-SPECIFIC TARGETING ELEMENTS (PASTE) (Massachusetts Institute of Technology)]] (20250320)
** [[20250101400. NOVEL CRISPR ENZYMES AND SYSTEMS (The Broad Institute, Inc.)]] (20250327)
** [[20250101400. NOVEL CRISPR ENZYMES AND SYSTEMS (The Broad Institute, Inc.)]] (20250327)
=== [[:Category:Shengkan Jin|Shengkan Jin of Belle Mead NJ (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
** [[:Category:Rutgers, The State University of New Jersey|Rutgers, The State University of New Jersey]]: 3 patents
* Recent patents:
** [[20250171808. Nuclease-Independent Targeted Gene Editing Platform and Uses Thereof (Rutgers, The State University of New Jersey)]] (20250529)
** [[20250163473. TARGETED GENE EDITING PLATFORM INDEPENDENT OF DNA DOUBLE STRAND BREAK AND USES THEREOF (Rutgers, The State University of New Jersey)]] (20250522)
** [[20250101464. Nuclease-Independent Targeted Gene Editing Platform and Uses Thereof (Rutgers, The State University of New Jersey)]] (20250327)
=== [[:Category:Juan-Carlos Collantes|Juan-Carlos Collantes of Princeton NJ (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
** [[:Category:Rutgers, The State University of New Jersey|Rutgers, The State University of New Jersey]]: 3 patents
* Recent patents:
** [[20250171808. Nuclease-Independent Targeted Gene Editing Platform and Uses Thereof (Rutgers, The State University of New Jersey)]] (20250529)
** [[20250163473. TARGETED GENE EDITING PLATFORM INDEPENDENT OF DNA DOUBLE STRAND BREAK AND USES THEREOF (Rutgers, The State University of New Jersey)]] (20250522)
** [[20250101464. Nuclease-Independent Targeted Gene Editing Platform and Uses Thereof (Rutgers, The State University of New Jersey)]] (20250327)
=== [[:Category:David R. Liu|David R. Liu of Cambridge MA (US)]] ===
=== [[:Category:David R. Liu|David R. Liu of Cambridge MA (US)]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 3
Line 260: Line 379:
** [[20250092374. EVOLVED CAS9 PROTEINS FOR GENE EDITING (President and Fellows of Harvard College)]] (20250320)
** [[20250092374. EVOLVED CAS9 PROTEINS FOR GENE EDITING (President and Fellows of Harvard College)]] (20250320)
** [[20250011748. BASE EDITORS, COMPOSITIONS, AND METHODS FOR MODIFYING THE MITOCHONDRIAL GENOME (The Broad Institute, Inc.)]] (20250109)
** [[20250011748. BASE EDITORS, COMPOSITIONS, AND METHODS FOR MODIFYING THE MITOCHONDRIAL GENOME (The Broad Institute, Inc.)]] (20250109)
=== [[:Category:William Douglass WRIGHT|William Douglass WRIGHT of Fairfield CA (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
** [[:Category:Mammoth Biosciences, Inc.|Mammoth Biosciences, Inc.]]: 3 patents
* Recent patents:
** [[20250154505. EFFECTOR PROTEINS AND METHODS OF USE (Mammoth Biosciences, Inc.)]] (20250515)
** [[20250145974. ENGINEERED CAS-PHI PROTEINS AND USES THEREOF (Mammoth Biosciences, Inc.)]] (20250508)
** [[20250101498. EFFECTOR PROTEINS, COMPOSITIONS, SYSTEMS, DEVICES, KITS AND METHODS OF USE THEREOF (Mammoth Biosciences, Inc.)]] (20250327)
=== [[:Category:Lucas Benjamin HARRINGTON|Lucas Benjamin HARRINGTON of San Francisco CA (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
** [[:Category:Mammoth Biosciences, Inc.|Mammoth Biosciences, Inc.]]: 3 patents
* Recent patents:
** [[20250154505. EFFECTOR PROTEINS AND METHODS OF USE (Mammoth Biosciences, Inc.)]] (20250515)
** [[20250144246. COMPOSITIONS AND METHODS FOR MODIFYING A HUMAN DYSTROPHIN GENE (Mammoth Biosciences, Inc.)]] (20250508)
** [[20250145974. ENGINEERED CAS-PHI PROTEINS AND USES THEREOF (Mammoth Biosciences, Inc.)]] (20250508)
=== [[:Category:Rui ZHU|Rui ZHU]] ===
* Number of Gene Editing patents: 3
* Top companies:
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 3 patents
* Recent patents:
** [[20250123466. HYBRID LENS AND OPTICAL SYSTEM (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
** [[20250123468. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
** [[20250123469. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
=== [[:Category:Clayton BEARD|Clayton BEARD of Durham NC (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:BridgeBio Gene Therapy Research, Inc.|BridgeBio Gene Therapy Research, Inc.]]: 2 patents
* Recent patents:
** [[20250114480. GENE THERAPY FOR GENETIC HEARING LOSS (BridgeBio Gene Therapy Research, Inc.)]] (20250410)
** [[20250001008. GENE THERAPY FOR GALACTOSEMIA (BridgeBio Gene Therapy Research, Inc.)]] (20250102)
=== [[:Category:Charles A. Gersbach|Charles A. Gersbach of Chapel Hill NC (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Duke University|Duke University]]: 2 patents
* Recent patents:
** [[20250114482. THERAPEUTIC APPLICATIONS OF CPF1-BASED GENOME EDITING (Duke University)]] (20250410)
** [[20250171754. CRISPR-CAS9 COMPOSITIONS AND METHODS WITH A NOVEL CAS9 PROTEIN FOR GENOME EDITING AND GENE REGULATION (Duke University)]] (20250529)
=== [[:Category:Tzu-Yao Lin|Tzu-Yao Lin]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED|GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED]]: 2 patents
* Recent patents:
** [[20250116761. OPTICAL DEPTH SENSING APPARATUS (GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED)]] (20250410)
** [[20250164758. IMAGING LENS (GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED)]] (20250522)
=== [[:Category:Shih-Chieh Yen|Shih-Chieh Yen]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED|GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED]]: 2 patents
* Recent patents:
** [[20250116761. OPTICAL DEPTH SENSING APPARATUS (GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED)]] (20250410)
** [[20250164758. IMAGING LENS (GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED)]] (20250522)
=== [[:Category:Leida Rassouli-Taylor|Leida Rassouli-Taylor of Philadelphia PA (US)]] ===
=== [[:Category:Leida Rassouli-Taylor|Leida Rassouli-Taylor of Philadelphia PA (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
Line 337: Line 508:
** [[20250066818. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.)]] (20250227)
** [[20250066818. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.)]] (20250227)
** [[20250075232. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.)]] (20250306)
** [[20250075232. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.)]] (20250306)
=== [[:Category:Cameron Myhrvold|Cameron Myhrvold of Princeton NJ (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:MASSACHUSETTS INSTITUTE OF TECHNOLOGY|MASSACHUSETTS INSTITUTE OF TECHNOLOGY]]: 1 patents
** [[:Category:The Trustees of Princeton University|The Trustees of Princeton University]]: 1 patents
* Recent patents:
** [[20250066842. SPLIT-LUCIFERASE REPORTER SYSTEMS, COLOR-CODED BEAD MULTIPLEX CRISPR SYSTEMS, AND METHODS OF USE THEREOF IN CRISPR-CAS BASED DIAGNOSTICS (MASSACHUSETTS INSTITUTE OF TECHNOLOGY)]] (20250227)
** [[20250146089. ABERRANT VIRAL RNA DETECTION USING CAS13 (The Trustees of Princeton University)]] (20250508)
=== [[:Category:Eric B. Kmiec|Eric B. Kmiec of Middletown DE (US)]] ===
=== [[:Category:Eric B. Kmiec|Eric B. Kmiec of Middletown DE (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
Line 389: Line 568:
** [[20250002881. CLASS II, TYPE V CRISPR SYSTEMS (Metagenomi, Inc.)]] (20250102)
** [[20250002881. CLASS II, TYPE V CRISPR SYSTEMS (Metagenomi, Inc.)]] (20250102)
** [[20250059568. CLASS II, TYPE V CRISPR SYSTEMS (METAGENOMI, INC.)]] (20250220)
** [[20250059568. CLASS II, TYPE V CRISPR SYSTEMS (METAGENOMI, INC.)]] (20250220)
=== [[:Category:Yi-Shan Chen|Yi-Shan Chen of South Boston MA (US)]] ===
=== [[:Category:Tirtha Chakraborty|Tirtha Chakraborty of Cambridge MA (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:CRISPR Therapeutics AG|CRISPR Therapeutics AG]]: 2 patents
** [[:Category:Vertex Pharmaceuticals Incorporated|Vertex Pharmaceuticals Incorporated]]: 1 patents
** [[:Category:VOR BIOPHARMA INC.|VOR BIOPHARMA INC.]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250043261. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250206)
** [[20250041349. CRISPR-CAS9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells and Uses Thereof (Vertex Pharmaceuticals Incorporated)]] (20250206)
** [[20250011743. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250109)
** [[20250140342. GENOTYPING CELLS USING SINGLE-CELL DNA SEQUENCING DATA (VOR BIOPHARMA INC.)]] (20250501)
=== [[:Category:Sandeep Soni|Sandeep Soni of South Boston CA (US)]] ===
=== [[:Category:James M. Wilson|James M. Wilson of Philadelphia PA (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:CRISPR Therapeutics AG|CRISPR Therapeutics AG]]: 2 patents
** [[:Category:The Trustees of the University of Pennsylvania|The Trustees of the University of Pennsylvania]]: 2 patents
* Recent patents:
* Recent patents:
** [[20250043261. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250206)
** [[20250041445. GENE THERAPY FOR TREATMENT OF MUCOPOLYSACCHARIDOSIS IIIA (The Trustees of the University of Pennsylvania)]] (20250206)
** [[20250011743. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250109)
** [[20250161493. COMPOSITIONS AND METHODS FOR IN VIVO NUCLEASE-MEDIATED TREATMENT OF ORNITHINE TRANSCARBAMYLASE (OTC) DEFICIENCY (The Trustees of the University of Pennsylvania)]] (20250522)
=== [[:Category:Laura Serwer|Laura Serwer of South Boston MA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:CRISPR Therapeutics AG|CRISPR Therapeutics AG]]: 2 patents
* Recent patents:
** [[20250043261. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250206)
** [[20250011743. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250109)
=== [[:Category:Jonathan Terrett|Jonathan Terrett of South Boston MA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:CRISPR Therapeutics AG|CRISPR Therapeutics AG]]: 2 patents
* Recent patents:
** [[20250043261. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250206)
** [[20250011743. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250109)
=== [[:Category:John Kulman|John Kulman of South Boston MA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:CRISPR Therapeutics AG|CRISPR Therapeutics AG]]: 2 patents
* Recent patents:
** [[20250043261. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250206)
** [[20250011743. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250109)
=== [[:Category:Benjamin OAKES|Benjamin OAKES of El Cerrito CA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Scribe Therapeutics Inc.|Scribe Therapeutics Inc.]]: 2 patents
* Recent patents:
** [[20250043262. GENE EDITING PAIRS (Scribe Therapeutics Inc.)]] (20250206)
** [[20250011756. METHODS OF EDITING WITH ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS (Scribe Therapeutics Inc.)]] (20250109)
=== [[:Category:Sean HIGGINS|Sean HIGGINS of Alameda CA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Scribe Therapeutics Inc.|Scribe Therapeutics Inc.]]: 2 patents
* Recent patents:
** [[20250043262. GENE EDITING PAIRS (Scribe Therapeutics Inc.)]] (20250206)
** [[20250011756. METHODS OF EDITING WITH ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS (Scribe Therapeutics Inc.)]] (20250109)
=== [[:Category:Sarah DENNY|Sarah DENNY of San Francisco CA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Scribe Therapeutics Inc.|Scribe Therapeutics Inc.]]: 2 patents
* Recent patents:
** [[20250043262. GENE EDITING PAIRS (Scribe Therapeutics Inc.)]] (20250206)
** [[20250011756. METHODS OF EDITING WITH ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS (Scribe Therapeutics Inc.)]] (20250109)
=== [[:Category:Brett T. STAAHL|Brett T. STAAHL of Tiburon CA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Scribe Therapeutics Inc.|Scribe Therapeutics Inc.]]: 2 patents
* Recent patents:
** [[20250043262. GENE EDITING PAIRS (Scribe Therapeutics Inc.)]] (20250206)
** [[20250011756. METHODS OF EDITING WITH ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS (Scribe Therapeutics Inc.)]] (20250109)
=== [[:Category:Isabel COLIN|Isabel COLIN of Oakland CA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Scribe Therapeutics Inc.|Scribe Therapeutics Inc.]]: 2 patents
* Recent patents:
** [[20250043262. GENE EDITING PAIRS (Scribe Therapeutics Inc.)]] (20250206)
** [[20250011756. METHODS OF EDITING WITH ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS (Scribe Therapeutics Inc.)]] (20250109)
=== [[:Category:Pravin Kumar R|Pravin Kumar R]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Kcat Enzymatic Private Limited|Kcat Enzymatic Private Limited]]: 1 patents
** [[:Category:KCAT ENZYMATIC PRIVATE LIMITED|KCAT ENZYMATIC PRIVATE LIMITED]]: 1 patents
* Recent patents:
** [[20250043292. INSILICO GUIDED CRISPR-CAS DRIVEN ENZYME ENGINEERING FRAMEWORK (Kcat Enzymatic Private Limited)]] (20250206)
** [[20250101476. SYNTHETIC BIOLOGY APPROACH TO SYNTHESIZE NICOTINIC ACID FROM 3-PICOLINE (KCAT ENZYMATIC PRIVATE LIMITED)]] (20250327)
=== [[:Category:Gladstone Sigamani G|Gladstone Sigamani G]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Kcat Enzymatic Private Limited|Kcat Enzymatic Private Limited]]: 1 patents
** [[:Category:KCAT ENZYMATIC PRIVATE LIMITED|KCAT ENZYMATIC PRIVATE LIMITED]]: 1 patents
* Recent patents:
** [[20250043292. INSILICO GUIDED CRISPR-CAS DRIVEN ENZYME ENGINEERING FRAMEWORK (Kcat Enzymatic Private Limited)]] (20250206)
** [[20250101476. SYNTHETIC BIOLOGY APPROACH TO SYNTHESIZE NICOTINIC ACID FROM 3-PICOLINE (KCAT ENZYMATIC PRIVATE LIMITED)]] (20250327)
=== [[:Category:Roopa L|Roopa L]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Kcat Enzymatic Private Limited|Kcat Enzymatic Private Limited]]: 1 patents
** [[:Category:KCAT ENZYMATIC PRIVATE LIMITED|KCAT ENZYMATIC PRIVATE LIMITED]]: 1 patents
* Recent patents:
** [[20250043292. INSILICO GUIDED CRISPR-CAS DRIVEN ENZYME ENGINEERING FRAMEWORK (Kcat Enzymatic Private Limited)]] (20250206)
** [[20250101476. SYNTHETIC BIOLOGY APPROACH TO SYNTHESIZE NICOTINIC ACID FROM 3-PICOLINE (KCAT ENZYMATIC PRIVATE LIMITED)]] (20250327)
=== [[:Category:Edwin Neumann|Edwin Neumann of Somerville MA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Whitehead Institute for Biomedical Research|Whitehead Institute for Biomedical Research]]: 2 patents
* Recent patents:
** [[20250019673. Compositions and Methods for Making Epigenetic Modifications (Whitehead Institute for Biomedical Research)]] (20250116)
** [[20250027059. Compositions and Methods for Making Epigenetic Modifications (Whitehead Institute for Biomedical Research)]] (20250123)
=== [[:Category:Tessa Bertozzi|Tessa Bertozzi of Cambridge MA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Whitehead Institute for Biomedical Research|Whitehead Institute for Biomedical Research]]: 2 patents
* Recent patents:
** [[20250019673. Compositions and Methods for Making Epigenetic Modifications (Whitehead Institute for Biomedical Research)]] (20250116)
** [[20250027059. Compositions and Methods for Making Epigenetic Modifications (Whitehead Institute for Biomedical Research)]] (20250123)
=== [[:Category:Jonathan Weissman|Jonathan Weissman of Cambridge MA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Whitehead Institute for Biomedical Research|Whitehead Institute for Biomedical Research]]: 2 patents
* Recent patents:
** [[20250019673. Compositions and Methods for Making Epigenetic Modifications (Whitehead Institute for Biomedical Research)]] (20250116)
** [[20250027059. Compositions and Methods for Making Epigenetic Modifications (Whitehead Institute for Biomedical Research)]] (20250123)
=== [[:Category:Jesse Salk|Jesse Salk of Seattle WA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION|UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION]]: 2 patents
* Recent patents:
** [[20250019761. METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING (UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION)]] (20250116)
** [[20250011866. METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING (UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION)]] (20250109)
=== [[:Category:Lawrence A. Loeb|Lawrence A. Loeb of Bellevue WA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION|UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION]]: 2 patents
* Recent patents:
** [[20250019761. METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING (UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION)]] (20250116)
** [[20250011866. METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING (UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION)]] (20250109)
=== [[:Category:Michael Schmitt|Michael Schmitt of Seattle WA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION|UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION]]: 2 patents
* Recent patents:
** [[20250019761. METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING (UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION)]] (20250116)
** [[20250011866. METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING (UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION)]] (20250109)
=== [[:Category:ZHENGLIN HOU|ZHENGLIN HOU of ANKENY IA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:PIONEER HI-BRED INTERNATIONAL, INC.|PIONEER HI-BRED INTERNATIONAL, INC.]]: 2 patents
* Recent patents:
** [[20250075197. ENGINEERED DEAMINASES (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250306)
** [[20250011804. INTERACTORS AND TARGETS FOR IMPROVING PLANT AGRONOMIC CHARACTERISTICS (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250109)
=== [[:Category:JOSHUA K. YOUNG|JOSHUA K. YOUNG of JOHNSTON IA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:PIONEER HI-BRED INTERNATIONAL, INC.|PIONEER HI-BRED INTERNATIONAL, INC.]]: 2 patents
* Recent patents:
** [[20250075197. ENGINEERED DEAMINASES (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250306)
** [[20250027097. HIGH EFFICIENCY LARGE SCALE CHROMOSOMAL GENOME MANIPULATION (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250123)
=== [[:Category:Omar Abudayyeh|Omar Abudayyeh of Cambridge MA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Massachusetts Institute of Technology|Massachusetts Institute of Technology]]: 1 patents
** [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]]: 1 patents
* Recent patents:
** [[20250092390. SYSTEMS, METHODS, AND COMPOSITIONS FOR SITE-SPECIFIC GENETIC ENGINEERING USING PROGRAMMABLE ADDITION VIA SITE-SPECIFIC TARGETING ELEMENTS (PASTE) (Massachusetts Institute of Technology)]] (20250320)
** [[20250101400. NOVEL CRISPR ENZYMES AND SYSTEMS (The Broad Institute, Inc.)]] (20250327)
=== [[:Category:Cynthia Hao|Cynthia Hao of Saratoga CA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Insitro, Inc.|Insitro, Inc.]]: 2 patents
* Recent patents:
** [[20250092456. IN SITU SEQUENCING OF RNA TRANSCRIPTS WITH NON-UNIFORM 5' ENDS (Insitro, Inc.)]] (20250320)
** [[20250101513. IN SITU SEQUENCING OF RNA TRANSCRIPTS WITH NON-UNIFORM 5' ENDS (Insitro, Inc.)]] (20250327)
=== [[:Category:Max R. Salick|Max R. Salick of San Francisco CA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Insitro, Inc.|Insitro, Inc.]]: 2 patents
* Recent patents:
** [[20250092456. IN SITU SEQUENCING OF RNA TRANSCRIPTS WITH NON-UNIFORM 5' ENDS (Insitro, Inc.)]] (20250320)
** [[20250101513. IN SITU SEQUENCING OF RNA TRANSCRIPTS WITH NON-UNIFORM 5' ENDS (Insitro, Inc.)]] (20250327)
=== [[:Category:Ci Chu|Ci Chu of Palo Alto CA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Insitro, Inc.|Insitro, Inc.]]: 2 patents
* Recent patents:
** [[20250092456. IN SITU SEQUENCING OF RNA TRANSCRIPTS WITH NON-UNIFORM 5' ENDS (Insitro, Inc.)]] (20250320)
** [[20250101513. IN SITU SEQUENCING OF RNA TRANSCRIPTS WITH NON-UNIFORM 5' ENDS (Insitro, Inc.)]] (20250327)


== Top Collaborations in Gene Editing ==
== Top Collaborations in Gene Editing ==
Line 579: Line 594:
[[File:Top_20_Cities_for_Gene_Editing_Inventors.png|border|800px]]
[[File:Top_20_Cities_for_Gene_Editing_Inventors.png|border|800px]]


* Cambridge: 56 inventors
* Cambridge: 92 inventors
* San Francisco: 25 inventors
* Shenzhen: 63 inventors
* Shenzhen: 24 inventors
* San Francisco: 48 inventors
* Shanghai: 23 inventors
* Shanghai: 40 inventors
* Philadelphia: 20 inventors
* Durham: 36 inventors
* Pleasanton: 17 inventors
* Seattle: 36 inventors
* South Boston: 17 inventors
* Philadelphia: 30 inventors
* San Diego: 14 inventors
* New York: 27 inventors
* La Jolla: 14 inventors
* San Diego: 27 inventors
* Seattle: 14 inventors
* Pleasanton: 25 inventors
* New York: 13 inventors
* Boston: 22 inventors
* Beijing: 13 inventors
* La Jolla: 21 inventors
* Boston: 12 inventors
* Oakland: 21 inventors
* Berkeley: 12 inventors
* South Boston: 21 inventors
* Oakland: 12 inventors
* Suwon-si: 20 inventors
* Suwon-si: 12 inventors
* London: 19 inventors
* Wuxi: 12 inventors
* Wuxi: 16 inventors
* Qingdao: 12 inventors
* Beijing: 16 inventors
* London: 11 inventors
* Berkeley: 15 inventors
* Milano: 10 inventors
* Baltimore: 13 inventors


[[Category:Gene Editing]]
[[Category:Gene Editing]]
[[Category:Patent Application Trends by Technology in 2025]]
[[Category:Patent Application Trends by Technology in 2025]]

Latest revision as of 04:41, 4 June 2025

Gene Editing Patent Application Filing Activity

Gene Editing patent applications in 2025

Top Technology Areas in Gene Editing

Top CPC Codes

Top Companies in Gene Editing 2025

The Regents of the University of California

SHENZHEN METALENX TECHNOLOGY CO.,LTD

THE BROAD INSTITUTE, INC.

PIONEER HI-BRED INTERNATIONAL, INC.

The Trustees of Columbia University in the City of New York

Tune Therapeutics, Inc.

The Broad Institute, Inc.

CRISPR THERAPEUTICS AG

The Trustees of the University of Pennsylvania

Illumina, Inc.

New Companies in Gene Editing (Last Month)

File:New Companies in Gene Editing Last Month.png

No new companies detected in the last month.

Emerging Technology Areas in Gene Editing

Top Companies in Emerging Gene Editing Technologies 2025

Top Inventors in Gene Editing

Chenglong HAO

Fengze TAN

Jian ZHU

Feng Zhang of Cambridge MA (US)

JOSHUA K. YOUNG of JOHNSTON IA (US)

Chris RAMSBORG of Seattle WA (US)

Mark L. BONYHADI of Sammamish WA (US)

Calvin CHAN of Seattle WA (US)

Pascal BEAUCHESNE of Seattle WA (US)

Alexandra Briner Crawley of Cary NC (US)

Tedd D. Elich of Durham NC (US)

Brian COSGROVE of Durham NC (US)

Kendra CONGDON of Durham NC (US)

Jason DEAN of Seattle WA (US)

Veronica GOUGH of Durham NC (US)

Joshua B. BLACK of Durham NC (US)

Britta JONES of Durham NC (US)

Heshan LIN

ZHENGLIN HOU of ANKENY IA (US)

Jonathan Gootenberg of Cambridge MA (US)

Shengkan Jin of Belle Mead NJ (US)

Juan-Carlos Collantes of Princeton NJ (US)

David R. Liu of Cambridge MA (US)

William Douglass WRIGHT of Fairfield CA (US)

Lucas Benjamin HARRINGTON of San Francisco CA (US)

Rui ZHU

Clayton BEARD of Durham NC (US)

Charles A. Gersbach of Chapel Hill NC (US)

Tzu-Yao Lin

Shih-Chieh Yen

Leida Rassouli-Taylor of Philadelphia PA (US)

Lior IZHAR

  • Number of Gene Editing patents: 2
  • Top companies:
  • Recent patents:
    • 20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.) (20250130)
    • [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)

Liat ROCKAH

  • Number of Gene Editing patents: 2
  • Top companies:
  • Recent patents:
    • 20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.) (20250130)
    • [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)

Nir HECHT

  • Number of Gene Editing patents: 2
  • Top companies:
  • Recent patents:
    • 20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.) (20250130)
    • [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)

Tyson D. Bowen of Morrisville NC (US)

Mark Moore of Durham NC (US)

Michael Lassner of Portland OR (US)

Andrew Garst of Pleasanton CA (US)

Ryan T. Gill of Pleasanton CA (US)

Tanya Elizabeth Warnecke Lipscomb of Pleasanton CA (US)

Cameron Myhrvold of Princeton NJ (US)

Eric B. Kmiec of Middletown DE (US)

Kelly H. Banas of Bear DE (US)

Joseph J. HIGGINS of Lexington MA (US)

Nancy CRAIG of Lexington MA (US)

Christopher BROWN of Albany CA (US)

Cindy CASTELLE of San Francisco CA (US)

Lisa ALEXANDER of Albany CA (US)

Tirtha Chakraborty of Cambridge MA (US)

James M. Wilson of Philadelphia PA (US)

Top Collaborations in Gene Editing

Top US States for Gene Editing Inventors


Top Cities for Gene Editing Inventors

  • Cambridge: 92 inventors
  • Shenzhen: 63 inventors
  • San Francisco: 48 inventors
  • Shanghai: 40 inventors
  • Durham: 36 inventors
  • Seattle: 36 inventors
  • Philadelphia: 30 inventors
  • New York: 27 inventors
  • San Diego: 27 inventors
  • Pleasanton: 25 inventors
  • Boston: 22 inventors
  • La Jolla: 21 inventors
  • Oakland: 21 inventors
  • South Boston: 21 inventors
  • Suwon-si: 20 inventors
  • London: 19 inventors
  • Wuxi: 16 inventors
  • Beijing: 16 inventors
  • Berkeley: 15 inventors
  • Baltimore: 13 inventors
Retrieved from "https://wikipatents.org/index.php?title=Gene_Editing_Patent_Application_Trends_2025&oldid=614074"
Cookies help us deliver our services. By using our services, you agree to our use of cookies.